Abstracts tagged "SLE and infection"

Abstract Number: 1594 • 2019 ACR/ARP Annual Meeting
High Expression of CD38 on CD8 T Cells Predicts Increased Burden of Infections in Patients with SLE
Lama Mulki¹, Abel Suarez-Fueyo ², Eri Katsuyama ², Vasileios Kyttaris ² and George Tsokos ², ¹Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, ²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Background/Purpose: We have previously reported that CD38 gene expression in the peripheral blood T cell from patients with SLE is increased. CD8+CD38+ T cells have…
Abstract Number: 2122 • 2018 ACR/ARHP Annual Meeting
CD38 over-Expression in CD8 Positive Cells Defines a Group of Patients with SLE Prone to Infections
Lama Mulki¹, Abel Suarez-Fueyo¹, Eri Katsuyama¹, Vasileios C. Kyttaris¹ and George C Tsokos², ¹Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Boston, MA, ²Division of Rheumatology, Department of Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Boston, MA
Background/Purpose: It has been previously shown by our laboratory that CD38 gene expression is increased in the peripheral blood T cell from patients with SLE.…
Abstract Number: 2653 • 2017 ACR/ARHP Annual Meeting
Exposure to a Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Increased SLE Severity
Harini Bagavant¹, Nina Wolska¹, Paulina Rybakowska¹, Magdalena Sroka¹, Astrid Rasmussen¹, Indra Adrianto¹, Felicia Qi², Courtney Montgomery¹, Kathy L. Sivils¹, Joel M. Guthridge³, Judith A. James¹, Joan T. Merrill¹ and Umesh Deshmukh¹, ¹Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²University of Oklahoma Health Sciences Center, Oklahoma City, OK, ³Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK
Background/Purpose: Infections are linked to morbidity in systemic lupus erythematosus (SLE). This study was undertaken to evaluate oral infections by dental plaque bacteria in SLE…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].